Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Biotech
Zag Bio emerges with $80M funding for Tregs diabetes candidate
Tregs bio Zag has emerged with backing from biopharma giants AbbVie, Regeneron and Sanofi, which are part of an $80 million series A financing round.
Kevin Dunleavy
Oct 28, 2025 7:00am
Sanofi drops toddler RSV vaccine after ph. 3 heads for failure
Oct 24, 2025 7:00am
Sanofi's $1.7B bet beats CSL's Zemaira in phase 2 face-off
Oct 22, 2025 10:35am
Electra shines with $183M fundraise for rare disease trial
Oct 22, 2025 8:26am
Regeneron, Sanofi receive 1- to 2-month priority review vouchers
Oct 17, 2025 8:30am
Evoq Therapeutics signs on with Sanofi in $500M partnership
Oct 16, 2025 10:25am
